Kennel Peter J, Rosenblum Hannah, Axsom Kelly M, Alishetti Shudhanshu, Brener Michael, Horn Evelyn, Kirtane Ajay J, Lin Edward, Griffin Jan M, Maurer Mathew S, Burkhoff Daniel, Sayer Gabriel, Uriel Nir
Division of Cardiology, Columbia University Irving Medical Center, New York Presbyterian Hospital, New York.
Division of Cardiology, Weill Cornell Medicine, New York Presbyterian Hospital, New York.
JAMA Cardiol. 2022 May 1;7(5):556-564. doi: 10.1001/jamacardio.2021.5090.
Heart failure (HF) is often characterized by an insidious disease course leading to frequent rehospitalizations and a high use of ambulatory care. Remote cardiac monitoring is a promising approach to detect worsening HF early and intervene prior to an overt decompensation.
Recently, a multitude of novel technologies for remote cardiac monitoring (RCM) in patients with HF have been developed and are undergoing clinical trials. This development has been accelerated by the COVID-19 pandemic.
This review summarizes the major clinical trials on RCM in patients with HF and present the most recent developments in noninvasive and invasive RCM technologies.
心力衰竭(HF)通常具有隐匿的病程,导致频繁再次住院以及门诊护理的高使用率。远程心脏监测是一种有前景的方法,可早期检测HF病情恶化并在明显失代偿之前进行干预。
最近,已开发出多种用于HF患者远程心脏监测(RCM)的新技术,并正在进行临床试验。COVID-19大流行加速了这一发展。
本综述总结了HF患者RCM的主要临床试验,并介绍了非侵入性和侵入性RCM技术的最新进展。